Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2021-2027

急性冠症候群(ACS)の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR0055
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:94
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、急性冠症候群(ACS)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(単剤療法、併用療法)、用途別市場規模(病院、外来手術センター、診断センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・急性冠症候群(ACS)の市場動向
・企業の競争状況、市場シェア
・急性冠症候群(ACS)の種類別市場規模(単剤療法、併用療法)
・急性冠症候群(ACS)の用途別市場規模(病院、外来手術センター、診断センター)
・急性冠症候群(ACS)の北米市場規模2016-2027(アメリカ、カナダ)
・急性冠症候群(ACS)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性冠症候群(ACS)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性冠症候群(ACS)の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性冠症候群(ACS)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Dexa Medica、GlaxoSmithKline、Novartis、Pfizer、Sanofi、Serum Institute of India、Biogen Inc、Eli Lilly and Company)
・結論

Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly, women, older patients, and patients with diabetes mellitus.
Increase in geriatric population and rise in the incidence of cardiac disorders are the major factors that drive the market growth. However, stringent government regulations for the approval of drugs are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA are expected to provide new growth opportunities for the market during the analysis period.

Market Analysis and Insights: Global Acute Coronary Syndrome (ACS) Market
The global Acute Coronary Syndrome (ACS) market size is projected to reach US$ 10110 million by 2026, from US$ 7806.3 million in 2019, at a CAGR of 3.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Coronary Syndrome (ACS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Coronary Syndrome (ACS) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Coronary Syndrome (ACS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Coronary Syndrome (ACS) market.

Global Acute Coronary Syndrome (ACS) Scope and Market Size
Acute Coronary Syndrome (ACS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Coronary Syndrome (ACS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dexa Medica
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Serum Institute of India
Biogen Inc
Eli Lilly and Company

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Coronary Syndrome (ACS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Acute Coronary Syndrome (ACS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Coronary Syndrome (ACS) Market Perspective (2016-2027)
2.2 Acute Coronary Syndrome (ACS) Growth Trends by Regions
2.2.1 Acute Coronary Syndrome (ACS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Coronary Syndrome (ACS) Historic Market Share by Regions (2016-2021)
2.2.3 Acute Coronary Syndrome (ACS) Forecasted Market Size by Regions (2022-2027)
2.3 Acute Coronary Syndrome (ACS) Industry Dynamic
2.3.1 Acute Coronary Syndrome (ACS) Market Trends
2.3.2 Acute Coronary Syndrome (ACS) Market Drivers
2.3.3 Acute Coronary Syndrome (ACS) Market Challenges
2.3.4 Acute Coronary Syndrome (ACS) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Coronary Syndrome (ACS) Players by Revenue
3.1.1 Global Top Acute Coronary Syndrome (ACS) Players by Revenue (2016-2021)
3.1.2 Global Acute Coronary Syndrome (ACS) Revenue Market Share by Players (2016-2021)
3.2 Global Acute Coronary Syndrome (ACS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Coronary Syndrome (ACS) Revenue
3.4 Global Acute Coronary Syndrome (ACS) Market Concentration Ratio
3.4.1 Global Acute Coronary Syndrome (ACS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Coronary Syndrome (ACS) Revenue in 2020
3.5 Acute Coronary Syndrome (ACS) Key Players Head office and Area Served
3.6 Key Players Acute Coronary Syndrome (ACS) Product Solution and Service
3.7 Date of Enter into Acute Coronary Syndrome (ACS) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Coronary Syndrome (ACS) Breakdown Data by Type
4.1 Global Acute Coronary Syndrome (ACS) Historic Market Size by Type (2016-2021)
4.2 Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Type (2022-2027)

5 Acute Coronary Syndrome (ACS) Breakdown Data by Application
5.1 Global Acute Coronary Syndrome (ACS) Historic Market Size by Application (2016-2021)
5.2 Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Coronary Syndrome (ACS) Market Size (2016-2027)
6.2 North America Acute Coronary Syndrome (ACS) Market Size by Type
6.2.1 North America Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021)
6.2.2 North America Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027)
6.2.3 North America Acute Coronary Syndrome (ACS) Market Size by Type (2016-2027)
6.3 North America Acute Coronary Syndrome (ACS) Market Size by Application
6.3.1 North America Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021)
6.3.2 North America Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027)
6.3.3 North America Acute Coronary Syndrome (ACS) Market Size by Application (2016-2027)
6.4 North America Acute Coronary Syndrome (ACS) Market Size by Country
6.4.1 North America Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021)
6.4.2 North America Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Coronary Syndrome (ACS) Market Size (2016-2027)
7.2 Europe Acute Coronary Syndrome (ACS) Market Size by Type
7.2.1 Europe Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021)
7.2.2 Europe Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027)
7.2.3 Europe Acute Coronary Syndrome (ACS) Market Size by Type (2016-2027)
7.3 Europe Acute Coronary Syndrome (ACS) Market Size by Application
7.3.1 Europe Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021)
7.3.2 Europe Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027)
7.3.3 Europe Acute Coronary Syndrome (ACS) Market Size by Application (2016-2027)
7.4 Europe Acute Coronary Syndrome (ACS) Market Size by Country
7.4.1 Europe Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021)
7.4.2 Europe Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size (2016-2027)
8.2 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Type
8.2.1 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Application
8.3.1 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Region
8.4.1 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Coronary Syndrome (ACS) Market Size (2016-2027)
9.2 Latin America Acute Coronary Syndrome (ACS) Market Size by Type
9.2.1 Latin America Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021)
9.2.2 Latin America Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027)
9.2.3 Latin America Acute Coronary Syndrome (ACS) Market Size by Type (2016-2027)
9.3 Latin America Acute Coronary Syndrome (ACS) Market Size by Application
9.3.1 Latin America Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021)
9.3.2 Latin America Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027)
9.3.3 Latin America Acute Coronary Syndrome (ACS) Market Size by Application (2016-2027)
9.4 Latin America Acute Coronary Syndrome (ACS) Market Size by Country
9.4.1 Latin America Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021)
9.4.2 Latin America Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size (2016-2027)
10.2 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Type
10.2.1 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Application
10.3.1 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Country
10.4.1 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dexa Medica
11.1.1 Dexa Medica Company Details
11.1.2 Dexa Medica Business Overview
11.1.3 Dexa Medica Acute Coronary Syndrome (ACS) Introduction
11.1.4 Dexa Medica Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.1.5 Dexa Medica Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Acute Coronary Syndrome (ACS) Introduction
11.2.4 GlaxoSmithKline Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Acute Coronary Syndrome (ACS) Introduction
11.3.4 Novartis Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Acute Coronary Syndrome (ACS) Introduction
11.4.4 Pfizer Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Acute Coronary Syndrome (ACS) Introduction
11.5.4 Sanofi Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Serum Institute of India
11.6.1 Serum Institute of India Company Details
11.6.2 Serum Institute of India Business Overview
11.6.3 Serum Institute of India Acute Coronary Syndrome (ACS) Introduction
11.6.4 Serum Institute of India Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.6.5 Serum Institute of India Recent Development
11.7 Biogen Inc
11.7.1 Biogen Inc Company Details
11.7.2 Biogen Inc Business Overview
11.7.3 Biogen Inc Acute Coronary Syndrome (ACS) Introduction
11.7.4 Biogen Inc Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.7.5 Biogen Inc Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Acute Coronary Syndrome (ACS) Introduction
11.8.4 Eli Lilly and Company Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Coronary Syndrome (ACS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Acute Coronary Syndrome (ACS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acute Coronary Syndrome (ACS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Coronary Syndrome (ACS) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acute Coronary Syndrome (ACS) Market Share by Regions (2016-2021)
Table 8. Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acute Coronary Syndrome (ACS) Market Share by Regions (2022-2027)
Table 10. Acute Coronary Syndrome (ACS) Market Trends
Table 11. Acute Coronary Syndrome (ACS) Market Drivers
Table 12. Acute Coronary Syndrome (ACS) Market Challenges
Table 13. Acute Coronary Syndrome (ACS) Market Restraints
Table 14. Global Acute Coronary Syndrome (ACS) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acute Coronary Syndrome (ACS) Market Share by Players (2016-2021)
Table 16. Global Top Acute Coronary Syndrome (ACS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Coronary Syndrome (ACS) as of 2020)
Table 17. Ranking of Global Top Acute Coronary Syndrome (ACS) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acute Coronary Syndrome (ACS) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Coronary Syndrome (ACS) Product Solution and Service
Table 21. Date of Enter into Acute Coronary Syndrome (ACS) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acute Coronary Syndrome (ACS) Revenue Market Share by Type (2016-2021)
Table 25. Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acute Coronary Syndrome (ACS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acute Coronary Syndrome (ACS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acute Coronary Syndrome (ACS) Revenue Market Share by Application (2016-2021)
Table 29. Global Acute Coronary Syndrome (ACS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acute Coronary Syndrome (ACS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Dexa Medica Company Details
Table 62. Dexa Medica Business Overview
Table 63. Dexa Medica Acute Coronary Syndrome (ACS) Product
Table 64. Dexa Medica Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 65. Dexa Medica Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Acute Coronary Syndrome (ACS) Product
Table 69. GlaxoSmithKline Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Acute Coronary Syndrome (ACS) Product
Table 74. Novartis Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Acute Coronary Syndrome (ACS) Product
Table 79. Pfizer Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Acute Coronary Syndrome (ACS) Product
Table 84. Sanofi Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Serum Institute of India Company Details
Table 87. Serum Institute of India Business Overview
Table 88. Serum Institute of India Acute Coronary Syndrome (ACS) Product
Table 89. Serum Institute of India Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 90. Serum Institute of India Recent Development
Table 91. Biogen Inc Company Details
Table 92. Biogen Inc Business Overview
Table 93. Biogen Inc Acute Coronary Syndrome (ACS) Product
Table 94. Biogen Inc Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 95. Biogen Inc Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Revenue in Acute Coronary Syndrome (ACS) Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly and Company Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Coronary Syndrome (ACS) Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Acute Coronary Syndrome (ACS) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Center Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Acute Coronary Syndrome (ACS) Report Years Considered
Figure 9. Global Acute Coronary Syndrome (ACS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Acute Coronary Syndrome (ACS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acute Coronary Syndrome (ACS) Market Share by Regions: 2020 VS 2027
Figure 12. Global Acute Coronary Syndrome (ACS) Market Share by Regions (2022-2027)
Figure 13. Global Acute Coronary Syndrome (ACS) Market Share by Players in 2020
Figure 14. Global Top Acute Coronary Syndrome (ACS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Coronary Syndrome (ACS) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Acute Coronary Syndrome (ACS) Revenue in 2020
Figure 16. Global Acute Coronary Syndrome (ACS) Revenue Market Share by Type (2016-2021)
Figure 17. Global Acute Coronary Syndrome (ACS) Revenue Market Share by Type (2022-2027)
Figure 18. North America Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Acute Coronary Syndrome (ACS) Market Share by Type (2016-2027)
Figure 20. North America Acute Coronary Syndrome (ACS) Market Share by Application (2016-2027)
Figure 21. North America Acute Coronary Syndrome (ACS) Market Share by Country (2016-2027)
Figure 22. United States Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Coronary Syndrome (ACS) Market Share by Type (2016-2027)
Figure 26. Europe Acute Coronary Syndrome (ACS) Market Share by Application (2016-2027)
Figure 27. Europe Acute Coronary Syndrome (ACS) Market Share by Country (2016-2027)
Figure 28. Germany Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Coronary Syndrome (ACS) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Acute Coronary Syndrome (ACS) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Acute Coronary Syndrome (ACS) Market Share by Region (2016-2027)
Figure 38. China Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Coronary Syndrome (ACS) Market Share by Type (2016-2027)
Figure 46. Latin America Acute Coronary Syndrome (ACS) Market Share by Application (2016-2027)
Figure 47. Latin America Acute Coronary Syndrome (ACS) Market Share by Country (2016-2027)
Figure 48. Mexico Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Coronary Syndrome (ACS) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Acute Coronary Syndrome (ACS) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Acute Coronary Syndrome (ACS) Market Share by Country (2016-2027)
Figure 54. Turkey Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Acute Coronary Syndrome (ACS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Dexa Medica Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 62. Serum Institute of India Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 63. Biogen Inc Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Acute Coronary Syndrome (ACS) Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[急性冠症候群(ACS)の世界市場規模・現状・予測2021年-2027年] (Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2021-2027 / QY21APR0055)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆